Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Prostate Cancer Progression
NCT04026230Phase 3Recruiting
- Sponsor
- Tampere University Hospital
- Start
- Aug 2019
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of atorvastatin in prostate cancer (PCa), sponsored by Tampere University Hospital. Started Aug 2019; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04026230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04026230.